A new study, published in the prestigious scientific journal Proceedings of the National Academy of Sciences (PNAS), challenges our natural human tendency to think that everything will necessarily get worse after a shock. Instead, the study presents compelling empirical evidence that it is possible to break the link between shocks and food insecurity. The key element for this is RESILIENCE. In simple terms, resilience means the ability of people, communities, ecosystems (and food systems in this particular case study) to withstand disturbance and to continue functioning despite disasters and shocks.   

A team of researchers from University of Toronto Engineering has created a new type of dye-sensitized nanoparticle that can detect target chemicals at very low concentrations, while also distinguishing between molecules with very similar shapes. 

When bound to their target molecules, the nanoparticles absorb light in the form of low-energy photons and use it to emit a high-energy photon. This chemical sensing ability could help pharmaceutical manufacturers detect impurities or enable researchers to find tiny traces of chemical pollutants in groundwater.

NY Creates (the New York Center for Research, Economic Advancement, Technology, Engineering, and Science) and Micron Technology, Inc., held a signing ceremony where 10 apprentices joined the first cohort of their joint workforce development program. Announced in April by Governor Kathy Hochul, the program provides hands-on training and education to help participants develop the in-demand skills that are critical for technician roles at Micron’s fabrication facilities, including its megafab under construction in Clay, New York. 

Artificial intelligence is transforming how information is generated, processed and stored, but its rapid expansion is also driving an unprecedented demand for computing power and electricity. Developing hardware that can process information more efficiently is therefore becoming one of the major technological challenges of the AI era.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. This technology from SUNY's University at Albany and Colorado State University allows technicians to simultaneously obtain ECG and EIT data from the same set of electrodes. Simultaneous multiple-current-source EIT uses an independent current source for each electrode, providing better control of the applied current density and increasing sensitivity to small changes, such as those caused by blood movement in the thorax. This sensitive EIT system can produce a regional ventilation-perfusion index for assessing lung health. The simultaneous acquisition of ECG waveforms provides exact cardiac timing that is useful when interpreting the EIT images. Additionally, combining time-aligned multi-electrode ECG waveforms with EIT data can both enhance EIT image reconstructions and enable reconstruction of the heart’s current-density source, providing additional clinical diagnostic capability. The combined EIT/ECG system is a more powerful clinical tool than either modality alone.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. This technology is a lung-targeting lipid nanoparticle (sLNP) system engineered for the precise delivery of anti-inflammatory agents to lung tissue, to treat acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The sLNPs are constructed from sulfonium lipids, which confer unique properties enabling selective accumulation in the lungs and robust, uniform expression of protein across all lung lobes. This approach sustains therapeutic protein expression directly within lung tissue while minimizing systemic exposure, thereby reducing potential side effects. What differentiates this technology is its lung specificity and the use of sulfonium lipid chemistry, which sets it apart from conventional amine-based lipid nanoparticles commonly used. Traditional LNPs lack organ selectivity, often requiring higher systemic doses that can increase toxicity and limit therapeutic efficacy, especially for lung diseases. In contrast, the sLNP platform enables targeted delivery and sustained local expression of therapeutics, overcoming the pharmacokinetic limitations and short half-life associated with systemic therapies. This targeted approach not only enhances therapeutic outcomes for ALI and ARDS but also opens avenues for treating other pulmonary inflammatory conditions and advancing pulmonary drug delivery. The technology’s novel combination of materials and delivery strategy positions it as a promising solution for unmet clinical needs in respiratory medicine.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. This technology is an on-chip quantum sensor platform that leverages arrays of individually addressable single-erbium ion qubits embedded within silicon-based hollow nanopillars. Utilizing advanced nanofabrication and materials engineering, the platform is fully compatible with standard semiconductor foundry processes, enabling scalable and cost-effective production. These quantum devices exhibit exceptional performance at room temperature, unattainable with current technologies.